Company ProfilePremium

Zibo Qixiang Tengda Chemical Co., Ltd.

Company Profile Analysis

Ticker: 002408.SZ淄博齐翔腾达化工股份有限公司

ESOMAR 23 Corporate BadgeISO Certifications Badge
Zibo Qixiang Tengda Chemical Co., Ltd. - Company showcase

Year Founded & Workforce

2002

3,460 Employees

Zibo Qixiang Tengda Chemical Co., Ltd. logo

Zibo Qixiang Tengda Chemical Co., Ltd. Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Zibo Qixiang Tengda Chemical Co., Ltd. Overview

Qixiang Tengda is China's leading independent C4 (four-carbon hydrocarbon) deep-processing chemical company, and is increasingly also a C3 (propane/propylene) producer. It converts refinery and cracker by-product streams into a flexible slate of solvents, rubber monomers, polymers and intermediates. Its anchor franchise is methyl ethyl ketone (MEK, butanone). The company describes its 260 kt/yr MEK capacity as the largest in China and in the world. Around this core sit maleic anhydride, butadiene made by butene oxidative dehydrogenation, butadiene rubber, nitrile latex, MMA, MTBE and tert-butanol. Since 2023 a 700 kt/yr propane dehydrogenation (PDH) unit has fed downstream propylene oxide (HPPO route) and acrylic acid capacity. A catalyst subsidiary, Qilu Keli, and a lower-margin international trading arm round out the group. After the 2022–2024 collapse of its former private parent (the Cedar/Xuesong group) and a court-led restructuring, the company has been controlled by Shandong Energy Group, one of China's largest provincial SOEs. Group revenue for FY2025 was CNY 23.8bn, and the company has been near breakeven-to-loss at the bottom of the chemical cycle.


Company's own description (FY2025 annual report, paraphrased)

Management describes the business as stable and organised around two pillars: chemical manufacturing and international trade. Its main products include MEK, maleic anhydride, propylene, rubber, butadiene, MMA, nitrile latex, tert-butanol, MTBE, propylene oxide, acrylic acid and a range of petroleum and chemical catalysts. Within manufacturing, management frames the company as a C4 specialist built on four "pivots": butene, isobutene, n-butane and isobutane. These streams pass through cracking, separation, conversion and refining, and then branch through oxidation, polymerisation and etherification routes. The resulting products are sold into solvents, synthetic rubber, artificial marble/unsaturated polyester, fuel additives and electronic chemicals. A C3 chain has been added along a propane → propylene → propylene oxide path, with acrylic acid and butyl acrylate as further derivatives. Management stresses that the plants are designed flexibly, so feedstock and product allocation can switch between chains as margins move.

Independent characterisation

Qixiang Tengda is a mid-cap, commodity-to-semi-specialty petrochemical processor with these characteristics:

Feedstock-spread economics: Earnings are driven by the spread between purchased C4/C3 feedstocks (mixed C4, n-butane, propane) and the realised prices of its products. Revenue is overwhelmingly product sales, with no meaningful subscription, licensing or service income. Catalysts sold by Qilu Keli are the closest thing to a technical-product business.

Mid-stream position: The company sits between the refiners and crackers that supply its C4/C3 streams (including Sinopec Qilu in the same Zibo industrial cluster, plus imported LPG/propane for PDH) and downstream converters. Those converters include coatings, adhesives, ink, synthetic leather, tyres, gloves, PMMA/acrylic sheet, polyurethane foam, unsaturated polyester resin and super-absorbent polymer producers.

Trade arm: The international trade segment adds roughly 35–37% of revenue at gross margins of about 2–3%. It inflates the top line, contributes little profit, and consumes working capital.

Customer types: The customers are industrial B2B buyers: domestic and overseas chemical converters, distributors and traders. No single-customer concentration is disclosed in the sources reviewed.

End-markets: These are coatings and inks, adhesives, synthetic leather, electronics cleaning, tyres and rubber goods, nitrile gloves, PMMA and optical/display materials, polyurethanes (furniture, autos), gasoline blending, and refinery/coal-chemical catalysts. Many are construction- and consumer-cyclical, and management explicitly cites property-linked demand weakness in FY2025.

Revenue model mix (FY2025)

Revenue typeFY2025 revenue (CNY Mn)Share of totalGross marginSource
Chemical manufacturing (product sales)14,69461.8%4.74%FY2025 AR via Lixinger
International trade8,84037.2%2.13%FY2025 AR via Lixinger
Other / other operating revenue2361.0%—Derived residual (total less segments)
Services / subscription / licensing00%—Not a disclosed revenue line

Strategy

Stated strategy themes (FY2025 AR and "Quality and Return" progress report, paraphrased)

  1. Deepen the C4 chain and keep leadership in MEK and maleic anhydride. Achieve this through refined operations, technical optimisation and stable, long-cycle plant runs.

  2. Optimise and extend the C3 chain (propane → propylene → PO; acrylic acid and butyl acrylate). Use process flexibility to switch between chains in response to margins.

  3. "Stock optimisation" rather than greenfield expansion. Extend existing chains into higher-value fine chemicals, specialty chemicals and new materials (anhydrous TBA, aldehyde series, MBS latex, high-performance catalysts).

  4. Innovation and technical revamps. The company ran 51 process revamp projects in FY2025. It uses a "targeted problem-solving" R&D model and partners with universities and institutes.

  5. Catalysts as a profit engine. Push Qilu Keli toward import substitution and a scaled, intelligent and green operating model.

  6. Globalisation. Use the Singapore, Switzerland and US hubs to take share during the window of overseas capacity exits, and strengthen international pricing power.

  7. Parent synergy. Lean on Shandong Energy Group for lower financing costs, governance standards and internal resource coordination.

  8. Shareholder returns and governance. Pursue stable cash dividends (suspended for FY2025 because of the loss), buybacks, better disclosure and ESG reporting.

Initiatives announced in the last 24 months

DateInitiativeDetail / targetStatus
Apr 2025"Quality and Return Dual Improvement" action planFocus on core business, innovation, governance, investor communication and returnsProgress report published Apr 2026
2,025Anhydrous tert-butanol projectHigher-purity TBA for high-end customersIn mass production
2,025Ether-cracking dual-route revampFlexibility on the isobutene / MTBE chainIn mass production
Aug 2025Qilu Keli 8 kt/yr high-performance catalytic materialsCNY 70M; import substitution and precious-metal thriftingCommissioned; contributing in H1 2026
2025–2026Aldehyde-based specialty chemicals (kiloton)New fine-chemical productsCommissioned
2,025Large-particle MBS latexPVC impact modifierCompleted
2,025Maleic anhydride consumption-optimisation seriesLower raw-material and solvent use per ton; higher steam by-product valueCompleted
FY202551 process technical revampsEfficiency and quality improvementCompleted / ongoing
Oct 2025Governance reformSupervisory board abolished; 18 governance policies revisedCompleted
Apr 20262026 FX hedging programmeUp to USD 30M notionalApproved
Apr 20262026 credit facilitiesUp to CNY 17bn in aggregateApproved by the AGM
2,026ESG reportingFY2025 ESG report published Apr 2026Ongoing

Cost programmes: No quantified group-wide cost-reduction target was disclosed. Management describes "lean production and refined management" and lower unit energy and material consumption in qualitative terms.

Medium-term financial targets and guidance

Not publicly disclosed. The company does not issue numeric revenue, margin or ROE targets. Its only forward-looking quantitative disclosures are statutory profit pre-announcements (for example, the H1 2026 net income range of CNY 110–121M).

Products & Services

Capacities are design capacities as disclosed. Where sources conflict, both figures are shown. Product-level pricing is commodity market-based, and no list pricing is disclosed.

C4 chain

ProductDescription & applicationsCapacity / specsTarget customerStatus / yearNotes
Methyl ethyl ketone (MEK, butanone) — flagshipHigh-purity solvent with strong solvency and moderate volatility. Used in coatings, adhesives, tapes, synthetic leather, inks and electronic cleaning. Positioned as a lower-toxicity replacement for benzene-series solvents and as an alternative to acetone.260 kt/yr design (after the 80 kt expansion announced 2021). The company says this is the largest in China and globally. China capacity was about 880 kt/yr in 2024.Coatings, adhesive and ink makers; exportersExpansion announced 2021, completed by FY2024Company claimed about 70% domestic production/sales share (FY2024 AR). A secondary source (dcf-analysis) cites 46% as of Dec 2025. The discrepancy is likely definitional (capacity vs. sales share); the primary filing is preferred.
ButadieneMonomer for synthetic rubbers (SBR, BR, NBR, CR), ABS/SBS resins, nylon-66 intermediates and THFUses butene oxidative dehydrogenation, which the company calls China's largest such process; it is not tied to ethylene-cracker scale.Mainly captive use (BR, nitrile latex)OperatingIntegration hedge against cracker-sourced butadiene volatility
Butadiene rubber (BR / 顺丁橡胶)Core compound for truck and passenger tyres110 kt/yr design (company statement, 2024)Tyre makersOperatingManagement linked 2024–2025 demand to heavy-truck tyres and infrastructure
Nitrile latex (丁腈胶乳)Base material for nitrile gloves and paper/textile coatingsExpansion of 200 kt/yr announced 2020Glove manufacturersOperatingExposed to the glove-industry cycle after the pandemic
Large-particle MBS latexImpact-modifier latex for PVCNew project completed in FY2025PVC compoundersCommissioned 2025Upgrade under "stock optimisation"
Maleic anhydride (顺酐)n-Butane oxidation route. Used in unsaturated polyester resin (artificial marble, FRP), fumaric/tartaric acid, lubricant additives, coatings, food/feed additives.200 kt/yr base plus a 200 kt/yr expansion announced 2021. A secondary source cites 150 kt/yr, and a 100 kt/yr unit was referenced in a 2024 maintenance notice. Total currently operating is not fully verified.UPR, chemicals, food/feedOperatingManagement ran a "maleic indicator optimisation" programme in FY2025 to cut raw-material and solvent consumption
MTBEGasoline octane enhancer from isobutene etherification—Refiners, fuel blendersOperatingEther-cracking dual-route revamp completed in FY2025
High-purity isobutene / tert-butanol (TBA), including anhydrous TBAIsobutene for pharmaceutical intermediates and polymers; anhydrous TBA for specialty solvents and intermediatesCapacity not disclosedPharma and fine chemicalsAnhydrous TBA commissioned 2025Higher value-add extension
MMA (methyl methacrylate)Monomer for PMMA (acrylic glass), coatings modifiers, display panels and battery encapsulation200 kt/yr (phase II completed Mar 2021)PMMA, coatings, electronicsOperatingFaces heavy Chinese capacity additions
IsooctaneClean gasoline blending componentCapacity not disclosedRefinersOperatingListed in the FY2023/FY2024 product lists
Aldehyde-based specialty chemicals (醛基系列)Kiloton-scale aldehyde specialty chemicals R&D-to-production projectKiloton scaleFine-chemical customersCommissioned 2025–2026Cited as an H1 2026 profit contributor
Isononanol (INA)Plasticiser alcohol200 kt/yr project (approved 2020)Plasticiser makers—May have been deferred; not referenced in FY2025 AR

C3 chain

ProductDescription & applicationsCapacity / specsTarget customerStatusNotes
Propylene (PDH)Propane dehydrogenation to polymer/chemical-grade propylene, feeding PO and acrylic acid700 kt/yrCaptive plus merchantFully on stream by 2023Exposed to imported propane (LPG) cost
Propylene oxide (PO)HPPO route (hydrogen peroxide direct oxidation), technology jointly developed by Evonik and thyssenkrupp; water is the only by-product. Used in polyether polyols for PU foam, coatings and electronic adhesives.300 kt/yr, with a 205 kt/yr high-concentration hydrogen peroxide plantPU polyol makersReady for start-up in 2023; operating sinceLower energy and environmental burden than the chlorohydrin route
Acrylic acidIntermediate for acrylate esters and SAP80 kt/yrEster and SAP producersOperating (project 2023)—
Butyl acrylateWaterborne coatings, adhesives, lithium-battery separator coatings60 kt/yrCoatings and adhesivesOperating—

Catalysts (Qilu Keli)

Product familyApplicationsNotes
Hydrocarbon steam-reforming (hydrogen production) catalystsRefinery and chemical hydrogen plantsLong-established line
Sulfur-tolerant shift catalystsCoal chemical and syngasCore product
Sulfur-recovery (Claus) catalystsRefinery and gas-plant environmental units—
Hydrotreating / hydrogenation catalystsRefining—
Fine-chemical catalysts and other purification agentsFine chemicals, environmental—
8 kt/yr high-performance catalytic new materials projectRaises in-house high-end catalyst supply; supports import substitution; R&D on precious-metal thrifting and lightweight synthesisCNY 70M capex, approved Aug 2025, commissioned before H1 2026

International trade services

OfferingDescriptionHubs
Chemical and energy product tradingExport of own products plus third-party chemical and energy trading; full-chain coordination from raw material to salesSingapore, Switzerland, USA, covering Southeast Asia, Europe, Latin America and Africa

Financial Narrative

Basis: PRC GAAP (CAS) consolidated statements as standardized by S&P Global Market Intelligence (via StockAnalysis.com), cross-checked with company-reported headline figures. Revenue is "revenue as reported" (operating revenue plus other revenue). FY2024 net income reflects the FY2025 retrospective restatement for CSRC Accounting Guideline No. 5 (deferred tax on convertible bonds). The original FY2024 figure was CNY 31.68M; restated it is CNY 34.45M.

Income statement

FY2025 basic EPS of CNY -0.20 is company-reported (Securities Star summary of the FY2025 AR). The company-reported FY2025 gross margin is 3.21%; the S&P-standardized figure is 3.04%, the difference being the treatment of other revenue.

Margins (%)

Revenue CAGR FY2021–FY2025: -9.2% per year (computed). The 3-year CAGR (FY2022–FY2025) is -7.3%.

Dividends per share (CNY)

FY2022: CNY 1.6 per 10 shares (CNY 455M total). FY2023: CNY 0.7058 per 10 shares (CNY 200M). FY2024: a CNY 0.3 per 10 final (CNY 84.6M), plus an interim that brings total FY2024 cash dividends to CNY 254M, implying about CNY 0.09 per share in total (computed). FY2025: nil.

Quarterly cadence

Derived: Q1 2025 is backed out from the Q1 2026 YoY change (+4.91% revenue, -1,796.62% net income). Q2 and Q3 2025 come from S&P quarterly data and the 9M 2025 loss of about CNY -146M. Q4 2025 is company-reported (CNY 5.558bn revenue, CNY -429M net income). Q2 2026 equals H1 2026 (revenue CNY 15.630bn, net income CNY 116.4M) less Q1 2026. Q1 2026 revenue is +4.9% YoY.

Balance sheet

At 30 Jun 2026: total assets were CNY 23.70bn (-3.35% vs. YE2025) and parent equity was CNY 11.21bn (+1.23%). The convertible bond (about CNY 679M outstanding) was repaid in cash on 19 Aug 2026, after the balance-sheet date.

Cash flow

H1 2026 operating cash flow was CNY 843M (+0.3% YoY). TTM to Jun 2026 FCF was about CNY 1.34bn (S&P).

Ratios

A secondary source cites annual interest expense of about CNY 239M. Against FY2024 EBIT of CNY 245M that implies coverage of about 1.0x, and against FY2025 EBIT coverage is negative. On an EBITDA basis, FY2025 coverage is about 4.8x. Financial expenses were CNY 65M in Q1 2026 alone. A media summary of the FY2025 AR put interest-bearing debt at 43.3% of total assets.

Commentary on trends, inflections and drivers

Revenue. Revenue peaked at CNY 34.9bn in FY2021, helped by a post-pandemic commodity spike and a large trading book. It then declined for four consecutive years to CNY 23.8bn in FY2025. Two forces drove the decline. First, prices for the main products fell as China's 2023–2025 wave of petrochemical capacity, which management calls one of the historical peaks of capacity release, met slowing property-linked demand. Second, the domestic supply-chain trading book was deliberately reshaped into "international trade". The decline is price-led, not volume-led: management says plant loads were kept on long, stable runs in FY2025.

Margins. Gross margin compressed from 12.5% to 3.0% over the period. The chemical segment margin halved in FY2025 alone (8.8% to 4.7%). Two structural factors amplified the cyclical squeeze: the large new C3 asset base and the depreciation that came with it. D&A rose from CNY 1.05bn in FY2021 to a peak of CNY 1.79bn in FY2023 as the PDH, PO and MMA assets entered service. That fixed-cost step-up means the operating line now breaks even only at higher spreads than before.

Net income. The FY2025 loss of CNY -575M was well below a sell-side consensus of about CNY 887M profit, per Securities Star. It was driven almost entirely by operations: asset impairments were only CNY 38.5M pre-tax, reducing net income by CNY 32.8M. Q4 2025 alone lost CNY 429M on revenue down 19% YoY.

Inflection in 2026. Q1 2026 remained loss-making (CNY -92M) with a 4.8% gross margin. Q2 2026 then swung to an estimated CNY 208M profit on revenue of about CNY 9.7bn. Management attributed this to three factors: an energy-price shock that lifted product prices, overseas capacity closures creating supply-demand mismatches, and a surge of more than 50% in overseas trade. By mid-September 2026 management said product prices had retreated from their March–April highs, but spreads remained better than in Q4 2025.

Balance sheet. Net debt rose from CNY 4.65bn to about CNY 7.4bn over the capex cycle (cumulative FY2021–FY2023 capex of CNY 12.7bn). Debt has also shifted short: short-term debt including current maturities reached CNY 8.3bn by FY2025, against cash of CNY 3.2bn. The current ratio of 0.63x and working capital of CNY -4.0bn are the most important balance-sheet vulnerabilities. They are mitigated by SOE-parent support, including access to the Shandong Energy Group Finance Company, and a CNY 17bn credit-line authorisation for 2026.

Cash flow. With capex down to about CNY 0.6–0.75bn per year, the company has generated positive FCF since FY2024 despite accounting losses. OCF of about CNY 1.3bn comfortably exceeds maintenance capex, and the cash cost base was sufficient to retire the CNY 679M convertible on time in August 2026.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Revenue by Segment

SegmentFY2023FY2024FY2025

Chemical manufacturing revenue (CNY Mn)

17,49916,70514,694

International trade / supply chain revenue (CNY Mn, FY2023 derived residual)

8,8968,1108,840

Other revenue (CNY Mn)

523404236

Total revenue (CNY Mn)

26,91825,21923,770

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Segment Margins & Growth (%) and Results by Segment

MetricFY2023FY2024FY2025

Chemical gross margin (%)

9.688.824.74

Chemical gross profit (CNY Mn)

1,6951,473696

Chemical share of revenue (%)

65.0166.2461.82

Chemical YoY revenue growth (%)

0-4.5-12.0

Segment Margins & Growth (%) and Results by Segment (FY2024–FY2025)

MetricFY2024FY2025

Trade gross margin (%)

2.772.13

Trade gross profit (CNY Mn)

225188

Trade share of revenue (%)

32.1637.19

Trade YoY revenue growth (%)

-8.89.0

Segment Margins & Growth (%)

MetricH1 2024H1 2025

Chemical revenue

7,7767,642

Chemical gross margin (%)

7.156.19

Trade revenue

—4,306

Trade gross margin (%)

—1.55

Group Entities

EntityOwnershipRole

Qingdao Siyuan Chemical Co., Ltd.

Wholly owned

Chemical manufacturing subsidiary (Qingdao)

Qixiang Tengda (Hong Kong) Co., Ltd.

Wholly owned

Offshore holding / trade

Zibo Tenghui Oil Chemical Co., Ltd.

Wholly owned

Oil/chemical processing

Shandong Qilu Keli Chemical Research Institute Co., Ltd.

—

Catalysts

Qixiang Huali New Materials Co., Ltd.

Wholly owned

New materials

Granite Capital S.A. (Switzerland)

Subsidiary; goodwill CGU

International trading hub

Zibo Qixiang Tengda Supply Chain Co., Ltd.

Wholly owned (per earlier reports)

Trading / supply chain

Zibo Linzi Petrochemical Fuel Co., Ltd.

100% (acquired 2020)

Feedstock / storage

Income Statement and Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Revenue (CNY Mn)

34,89229,81026,91825,21923,770

Revenue growth YoY (%)

41.34-14.56-9.70-6.31-5.75

Cost of revenue (CNY Mn)

30,51527,24525,31723,83323,047

Gross profit (CNY Mn)

4,3772,5651,6021,386723

SG&A (CNY Mn)

561636460428417

R&D expense (CNY Mn)

579706655675668

Operating income (CNY Mn, derived: GP less opex)

3,1101,108451245-372

EBITDA (CNY Mn, derived from S&P EV/EBITDA)

4,1512,3242,2371,9761,158

Depreciation & amortization (CNY Mn)

1,0511,2241,7931,7411,538

Net income attributable to parent (CNY Mn)

2,393634-38434-575

Net income excl. non-recurring items (CNY Mn, company-reported)

00-25315-583

EPS basic (CNY, computed NI/weighted shares approx.)

0.840.22-0.140.01-0.20

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Gross margin (%)

12.548.605.955.503.04

Operating margin (%)

8.913.721.680.97-1.57

EBITDA margin (%)

11.907.808.317.844.87

Net margin (%)

6.862.13-1.430.14-2.42

R&D / revenue (%)

1.662.372.432.682.81

Per-Share Data

MetricFY2022FY2023FY2024FY2025

Dividend per share (CNY, declared for the year)

0.1600.07060.0900.000

Income Statement

MetricQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Revenue (CNY Mn)

5,6186,5906,0005,5585,8949,736

Net income attributable (CNY Mn)

518-169-429-92208

Balance Sheet and Per-Share Data

MetricFY2021FY2022FY2023FY2024FY2025

Total assets (CNY Mn)

26,07129,00126,78025,36124,524

Cash & equivalents (CNY Mn)

2,6032,6093,1112,9013,188

Accounts receivable (CNY Mn)

4,2454,3992,0362,2291,751

Inventory (CNY Mn)

1,1951,4771,7641,1851,489

PP&E (CNY Mn)

11,53715,57515,09814,43913,434

Short-term debt incl. current LTD (CNY Mn)

4,2965,3876,3697,3628,314

Long-term debt (CNY Mn)

2,9513,3513,1062,9972,295

Total debt incl. leases (CNY Mn)

7,2588,7599,94710,47510,627

Net debt (CNY Mn)

4,6526,1486,8347,5707,403

Total equity (CNY Mn)

13,42014,08612,31511,87311,229

Equity attributable to parent (CNY Mn)

12,79013,48811,80111,66111,071

Goodwill (CNY Mn)

1,004922641641641

Other intangibles (CNY Mn)

1,4811,5101,7311,6171,603

Working capital (CNY Mn)

-464-1,791-3,522-3,717-4,018

Book value per share (CNY)

4.504.744.164.143.93

Cash Flow

MetricFY2021FY2022FY2023FY2024FY2025

Operating cash flow (CNY Mn)

2,0401,4606611,3521,303

Capital expenditure (CNY Mn)

5,7824,6332,313753632

Free cash flow (CNY Mn)

-3,741-3,173-1,652599670

Dividends paid (CNY Mn)

718810590504262

Share buybacks (CNY Mn)

0001200

Net debt issued / (repaid) (CNY Mn)

1,8211,6791,4271,184340

Returns & Leverage Ratios (%) and Financial Ratios (x)

MetricFY2021FY2022FY2023FY2024FY2025

ROE (%)

21.094.35-3.470.39-4.82

ROA (%, S&P basis)

8.322.521.010.59-0.93

ROIC (%)

17.704.822.291.16-1.96

Current ratio (x)

0.950.840.680.640.63

Quick ratio (x)

0.730.660.470.500.47

Debt / equity (x)

0.540.620.810.880.95

Net debt / EBITDA (x)

1.122.653.063.836.40

Asset turnover (x)

1.491.080.970.970.95

Inventory turnover (x)

31.2320.4015.6316.1717.24

DSO (days, computed year-end)

44.453.927.632.326.9

DIO (days, computed)

11.717.923.422.621.2

DPO (days, computed year-end)

33.649.527.422.525.4

Cash conversion cycle (days, computed)

22.522.323.632.422.7

Geographic Revenue

ItemDetailSource

Overseas trade growth

More than 50% YoY in H1 2026

H1 2026 profit pre-announcement, 10 Jul 2026

Regional hubs

Singapore, Switzerland, USA, covering Southeast Asia, Europe, Latin America and Africa

FY2025 AR

FX exposure

Mainly USD; FX hedging capped at USD 30M notional at any point for 2026

FX derivatives notice, Apr 2026

Share Price and Market Valuation

MetricFY2021FY2022FY2023FY2024FY2025

Year-end share price (CNY)

9.936.665.125.004.88

Year-end market cap (CNY Mn)

29,84720,01315,01014,18513,762

Valuation Multiples

MultipleQixiang Tengda

P/E (TTM)

Not meaningful (TTM loss)

EV/EBITDA

15.6x (FY2025: 18.7x)

EV/Sales

0.81x

P/S

0.54x

P/B

1.30x

P/TBV

1.63x

P/FCF

11.0x

FCF yield

9.1%

Analyst Ratings & Targets

BrokerDateRatingTarget

Changjiang Securities (Wei Kai, Hou Yanfei)

15 Apr 2026

Buy

Not stated

Changjiang Securities

11 Nov 2025

Buy

Not stated

Changjiang Securities

9 May 2025

Buy

Not stated

Guotai Haitong

23 Apr 2025

Overweight

CNY 5.30

Dividends & Capital Returns and Returns & Leverage Ratios (%)

MetricFY2022FY2023FY2024FY2025

Total cash dividends declared (CNY Mn)

4552002540

Payout vs. net income attributable (%)

7207370

Credit Ratings

AgencyRatingOutlookDate

China Lianhe Credit Rating (issuer and convertible)

AA

Stable

2025 surveillance

Moody's / S&P / Fitch

Not rated

——

Bucket Details

BucketAmount (CNY Mn)

Short-term borrowings

6,910

Current portion of long-term debt (incl. convertible due Aug 2026)

1,404

Long-term debt (due after 2026)

2,295

Leases

18

Total debt

10627

Analyst Conclusions

Management guidance

No numeric full-year guidance has been given. Qualitatively, management describes the industry in mid-September 2026 as being in a weak recovery. It expects price recovery as downstream restocking resumes and the maintenance season ends, and it will continue cost reduction and process optimisation to protect reasonable profitability. The Q3 2026 report is due by 31 Oct 2026.

Consensus expectations

A verified consensus is not available. The single active broker (Changjiang) rates the stock Buy. The previous consensus for FY2025 profit (about CNY 887M) proved far too high, so street numbers should be treated with caution.

Bull case

  1. Operating leverage on a fixed asset base. Q2 2026 alone produced about CNY 208M of net income on about CNY 9.7bn of revenue. Annualising even half of that spread environment implies a return to positive earnings, and EV/EBITDA would compress quickly from 15.6x.

  2. Structural share gain abroad. Overseas capacity exits and a working three-hub trading network (overseas trade up more than 50% in H1 2026) could make exports a durable outlet for China's #1 MEK producer.

  3. De-risked balance sheet and capex holiday. Capex is down 89% from its FY2021 peak, FCF is positive (about CNY 1.3bn TTM), the convertible is repaid, and SOE backing exists. Deleveraging and a resumption of dividends are plausible in 2027.

Bear case

  1. Chinese overcapacity is structural. MMA, PO, acrylics and butadiene face continuing new supply. FY2025's 3% gross margin may be closer to the new normal than FY2021's 12.5%.

  2. Short-dated leverage. Net debt of CNY 7.4bn, a current ratio of 0.63x and net debt/EBITDA of 6.4x leave little cushion if the H1 2026 price spike fully reverses, as September commentary suggests is partly happening.

  3. Governance and minority-holder alignment. A 53% SOE controller, related-party flows, pledged parent shares, low institutional ownership and repeated leadership reshuffles (chairman change in Sep 2026) may cap the valuation multiple regardless of the cycle.

Catalysts and monitorables (next 12 months)

  • Q3 2026 results (by 31 Oct 2026): whether Q2's profitability held as product prices eased.

  • MEK–butane, maleic anhydride–butane and PO–propane spreads.

  • Strategy statements from new Chairman Sun Qingtao and GM Liu Fuliang; the EGM to seat Luan Fusheng.

  • Overseas revenue share in the FY2026 annual report (expected Apr 2027).

  • FY2026 dividend decision, given CNY 4.46bn of distributable profit.

  • Net debt trajectory and short-term debt refinancing after the convertible repayment.

  • Policy implementation of capacity rationalisation ("anti-involution") in Chinese petrochemicals.

  • Any Shandong Energy asset-optimisation or synergy announcements (currently unconfirmed).

  • Safety and environmental performance at the Zibo complex.

Analyst verdict

Qixiang Tengda is a company with one genuinely advantaged franchise, MEK, attached to a larger portfolio of mid-scale commodity chains and a low-margin trading book. The FY2021–FY2023 investment cycle (PDH, HPPO PO, MMA, acrylics) roughly doubled the fixed-cost base just as China's petrochemical industry entered what management calls one of its largest capacity waves. The result was predictable: four years of falling revenue, gross margin compressed to about 3%, a CNY 575M loss in FY2025, and net debt/EBITDA above 6x.

The 2026 picture is better but not yet proven. H1 2026 showed the earnings torque of the asset base: net income of CNY 116M and a strong Q2 driven by an energy-price spike and overseas share gains. However, management itself frames the backdrop as a weak recovery, and product prices had already retreated from their spring highs by September. The Q2 2026 profit should therefore be treated as partly cyclical windfall rather than a new run-rate.

Two factors keep the balance of risks tolerable for patient capital. First, the company now generates real free cash flow: capex is a fraction of peak, FCF is about CNY 1.3bn TTM, and it retired its CNY 679M convertible in cash. Second, its SOE parent supplies credit and governance support that the former private owner could not. The negatives are equally clear: a short-dated debt stack, minority-shareholder alignment questions, and a fresh leadership transition whose strategic agenda is unknown.

On balance, at about 1.3x book and 0.8x EV/Sales the shares price in a slow recovery but not a structural one. We would characterise the stock as a cyclical "hold / accumulate on weakness" for investors with a view on Chinese chemical-capacity discipline. The key confirmations to watch are Q3–Q4 2026 margins, net-debt reduction and a resumption of dividends. Without these, the bear case of a permanently lower margin structure remains credible.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleSinceBackgroundAge / born

Sun Qingtao (孙清涛)

Chairman; Party Secretary; Chair of Strategy Committee; Nomination Committee member

Chairman since 29 Sep 2026; previously Director and GM

Career at the Yankuang/Yanzhou Coal group: Lunan Fertilizer, Ordos Energy Chemical, Xinjiang Coal Chemical (GM), Yankuang Coal Chemical Engineering (Executive Director/GM), Yulin Energy Chemical (Chairman). Also Deputy GM of SNE New Materials. Master of Engineering; professor-level senior engineer.

Born May 1972 (54)

Liu Fuliang (刘付亮)

General Manager; Director

GM since 29 Sep 2026; previously Executive Deputy GM

Yankuang International Coking; Ordos Energy Chemical; Shaanxi Future Energy coal-to-liquids; Yankuang Yulin Fine Chemical (HSE section chief, production centre director). Director of Tianchen Qixiang. Bachelor's; senior engineer; registered safety engineer.

Born Dec 1981 (44)

Huang Liang (黄亮)

Deputy General Manager

29 Sep 2026

Joined the company in 2011 as a technician, rising to plant manager; later head of Safety Supervision / Eco-environment at SNE New Materials. Postgraduate; engineer.

Born Dec 1985 (40)

Wang Yanxin (王彦鑫)

Chief Financial Officer

In role since at least H1 2024

——

Jiang Nengcheng (姜能成)

Board Secretary; Director

Board Secretary by FY2025 AR; succeeded Su Chao

——

Rong Fang (荣芳)

Head of Accounting

In role since at least H1 2024

——

“—” = not publicly disclosed.

Board of Directors

NameRoleIndependenceNotes

Sun Qingtao

Chairman

Executive / shareholder-affiliated (SNE New Materials)

—

Liu Fuliang

Director, GM

Executive

Strategy Committee member

Zhu Hui (朱辉)

Non-independent director

—

Elected Jun 2026

Jiang Nengcheng

Director, Board Secretary

Executive

—

Sun Wenli (孙文丽)

Employee-representative director

Employee director

Born Feb 1976. Party Discipline Secretary, Deputy Party Secretary and union chair. Formerly at Shandong Donghua Cement (Zibo Mining group). FY2025 pay about CNY 0.52M (Lixinger).

Wang Ming (王鸣)

Independent director

Independent

Chair of Nomination Committee; Strategy Committee member

Huang Yede (黄业德)

Independent director

Independent; accounting expert

—

Fu Xu (付旭)

Independent director

Independent

Strategy Committee member; joined Jun 2026

Luan Fusheng (栾馥升)

Nominee (pending EGM)

Shareholder-affiliated

Born Mar 1986. Deputy Chief Economist and head of Operations Management at SNE New Materials. Fills the seat vacated by Li Qingwen.

Li Qingwen (李庆文)

Former Chairman

—

Resigned for "work adjustment" (late Sep 2026); held no shares

Board & Management Changes

DateChangeContext

29 Sep 2026

Li Qingwen resigned as Chairman and Director; Sun Qingtao elected Chairman; Liu Fuliang appointed GM; Huang Liang appointed Deputy GM; Luan Fusheng nominated as director

Parent-driven reshuffle, described as a "work adjustment"

Jun 2026

Seventh board elected; Li Qingwen re-elected Chairman; Fu Xu joined as independent director

Regular three-year renewal

Oct 2025

Supervisory board abolished; employee-representative director seat added

New Company Law compliance

2024–2025

Board Secretary changed from Su Chao to Jiang Nengcheng

—

2023–2025

Founder Che Chengju moved from GM to non-executive status; Sun Qingtao became GM

—

Apr 2023

Director Chen Hui (Cedar appointee) unreachable

Legacy Cedar governance breakdown

Major Shareholders

RankHolderTypeStakeShares
1

Shandong Energy Group New Materials Co., Ltd.

State-owned legal person

53.18%1,511,964,163
2

Che Chengju (founder)

Individual

4.30%122,120,811
3

Chang'an Trust – Qixiang Tengda Employee Stock Ownership Plan No. 1

ESOP trust

2.65%75,386,218
4

Hong Kong Securities Clearing (Northbound Stock Connect)

Foreign legal person

0.79%22,449,583
5

Mei Jingming

Individual (margin account)

0.50%14,164,905
6

Yang Cuilan

Individual

0.46%13,186,200
7

Wang Hairong

Individual (margin account)

0.31%8,900,000
8

Song Yilong

Individual

0.23%6,525,340
9

Sun Tao

Individual

0.22%6,250,000
10

Cedar (Xuesong) Industrial Group

Private legal person

0.21%6,109,040

Competitive Landscape

Competitors by Segment

Segment / productNamed competitorsRelative positioning

MEK

ExxonMobil; Shell; Sasol; Maruzen Petrochemical (Japan); Idemitsu Kosan (Japan); Formosa Plastics (Taiwan); PetroChina refinery MEK units; Sinopec-affiliated units

Company claims the #1 global capacity (260 kt/yr) and about 70% of domestic production and sales. China capacity is about 880 kt/yr in total, so other Chinese producers are smaller.

Maleic anhydride

Other n-butane-route Chinese producers (Shandong and Jiangsu clusters); Huntsman (global); Lanxess (benzene route)

—

Butadiene / BR

Sinopec; PetroChina (cracker-based butadiene and BR); private refiners

Company differentiated by its non-cracker butene-ODH route; much smaller BR scale than the majors

MMA

Wanhua Chemical; Mitsubishi Chemical (Lucite); Röhm; several new Chinese C4/ACH-route entrants

Mid-scale; under heavy price pressure from new capacity

PDH / propylene

Oriental Energy (Donghua Energy); Satellite Chemical; Jinneng Science & Technology; Wanhua Chemical

700 kt/yr is mid-sized versus leading PDH operators

Propylene oxide

Wanhua Chemical; Sinopec (SM/PO); Satellite / Jiangsu-based HPPO plants; Dow; LyondellBasell

300 kt/yr HPPO is competitive on technology, but the market is oversupplied

Acrylic acid / butyl acrylate

Satellite Chemical; Wanhua Chemical; BASF-YPC

Small scale (80/60 kt/yr)

Catalysts (Qilu Keli)

Sinopec Catalyst Co.; Johnson Matthey; Haldor Topsoe (Topsoe); Clariant

Niche domestic supplier in shift, sulfur-recovery and hydrogen catalysts

Trading

Chinese and global chemical traders

Commodity-like; low margin

Competitor Detail

MetricQixiang Tengda (FY2025)

Revenue

CNY 23.8bn

Revenue growth

-5.8%

Gross margin

3.0–3.2%

Net margin

-2.4%

R&D intensity

2.8%

Company Snapshot

$3,306M

Revenue

3,460

Employees

2002

Founded

Shandong Province, China

Headquarters

SWOT Analysis

Strengths

  • Global MEK leadership. 260 kt/yr design capacity, about 30% of China's roughly 880 kt/yr, and a claimed 70% domestic sales share (FY2024 AR).
  • SOE parent support. Shandong Energy Group holds 53.18% and the company's ultimate controller is Shandong SASAC. The company has access to the group finance company, an AA/stable credit rating, and CNY 17bn of approved 2026 credit lines.
  • Integrated, flexible C4/C3 flowsheet. Plants are designed to switch between products. This lets the company keep running at full load through the trough; management reports long-cycle stable operation in FY2025.
  • Positive FCF through the trough. FCF was CNY 670M in FY2025 despite a CNY 575M accounting loss, and TTM FCF to Jun 2026 was about CNY 1.34bn (S&P).
  • Clean-technology PO asset. 300 kt/yr HPPO with Evonik/thyssenkrupp technology and a captive 700 kt/yr PDH and 205 kt/yr hydrogen peroxide supply.
  • Catalyst technology platform. Qilu Keli's steam-reforming, shift, sulfur-recovery and hydrotreating catalysts, with a new 8 kt/yr high-performance plant commissioned in 2025–2026.
  • Debt-maturity execution. The CNY 679M convertible was repaid in cash at maturity on 19 Aug 2026 with no default.

Weaknesses

  • Margin collapse. Group gross margin fell from 12.5% (FY2021) to 3.0% (FY2025). Chemical segment gross margin was 4.74% in FY2025, versus 9.68% in FY2023.
  • Liquidity mismatch. The current ratio was 0.63x and working capital CNY -4.0bn at YE2025. Short-term debt including current maturities was CNY 8.3bn, against cash of CNY 3.2bn.
  • High leverage relative to earnings. Net debt to EBITDA was 6.4x in FY2025, versus 1.1x in FY2021, and interest-bearing debt was about 43% of assets.
  • Low-margin trade dilution. Trade is 37% of revenue at a 2.1% gross margin and only about a quarter of gross profit.
  • Earnings volatility and forecasting misses. The FY2025 loss of CNY -575M compares with a consensus of about CNY +887M profit.
  • Persistent revenue decline. Revenue CAGR was -9.2% from FY2021 to FY2025, with four consecutive years of decline.
  • Shareholder-return interruption. There was no FY2025 dividend, after CNY 254M was paid for FY2024.

Opportunities

  • Overseas capacity exits. Overseas trade revenue rose more than 50% YoY in H1 2026, and management targets higher global share and pricing power.
  • China "anti-involution" capacity discipline. The MIIT 2025–2026 plan for steady growth in petrochemicals discourages duplicated low-end capacity.
  • Specialty upgrades. Anhydrous TBA, the aldehyde series, MBS latex and high-performance catalysts were all cited as profit contributors in H1 2026.
  • Catalyst import substitution. Management's stated goal is to make catalysts a new profit model.
  • Parent synergies and possible asset optimisation within Shandong Energy's chemical portfolio. These are speculative and have not been announced.
  • Operating leverage on recovery. Q2 2026 net income of about CNY 208M on revenue of about CNY 9.7bn shows the earnings power once spreads normalise, given a largely fixed D&A base of about CNY 1.5–1.7bn.

Threats

  • New domestic capacity in MMA, PO, acrylic acid and butadiene. Management explicitly cites intensifying homogeneous competition and a longer recovery cycle.
  • Energy and feedstock volatility. The H1 2026 price spike reversed by September 2026 (management Q&A, 14 Sep 2026).
  • Tariffs and geopolitics. These are cited as drivers of the H1 2025 profit decline and pose risks to the export strategy.
  • Property-linked demand weakness in coatings and adhesives, the core MEK end-uses (FY2025 AR).
  • Refinancing risk if bank appetite tightens, given the reliance on short-term debt.
  • Safety and environmental incidents inherent in a hazardous-chemicals complex. The new GM is a registered safety engineer, which suggests the topic has priority.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
10 Apr 2025FY2024 results: revenue CNY 25.2bn (-6.3%); net income CNY 31.7M (later restated to CNY 34.5M); final dividend CNY 0.3 per 10 sharesNear-breakeven trough year
10 Apr 2025"Quality and Return Dual Improvement" action plan publishedShareholder-return framework
23 Apr 2025Guotai Haitong rated the stock Overweight with a CNY 5.30 targetSell-side coverage
30 Apr 2025Q1 2025 report; convertible outstanding CNY 679.4MBond overhang
May 2025Changjiang Securities reiterated BuyCoverage
12 Jul 2025H1 2025 pre-announcement: net income CNY 19–28.5M, down 79–86% YoY; blamed on geopolitics, tariff uncertainty, weak demand and competitionProfit warning
22 Aug 2025H1 2025 report: net income CNY 23.2M; Qilu Keli 8 kt/yr catalyst project (CNY 70M) approved; 2025 related-party cap raised by CNY 100MInvestment in upgrades
Oct 2025Supervisory board abolished; employee director addedGovernance reform
Oct 2025Q3 2025 report: 9M net loss about CNY -146M; Q3 revenue CNY 6.0bnSwing to loss
11 Nov 2025Changjiang Securities reiterated BuyCoverage
10 Dec 2025Board declined a downward revision of the convertible's conversion price and froze revision until 10 Mar 2026Signalled cash repayment over dilution
6 Jan 2026Q4 2025 conversion report: CNY 679.3M of the convertible outstandingMaturity approaching
8–10 Apr 2026FY2025 results: revenue CNY 23.77bn (-5.75%); net income CNY -574.5M; Q4 loss CNY -429M; no dividend; impairments CNY 38.5M; auditor reappointed; CNY 17bn credit lines; ESG reportDeep loss, far below consensus
10 Apr 2026Accounting policy change (CSRC Guideline No. 5) with retrospective restatementMinor restatement
15 Apr 2026Changjiang Securities reiterated BuyCoverage
17 Apr 2026FY2025 online earnings briefing (GM, CFO, Board Secretary, independent director)Investor communication
Apr 2026Q1 2026 report: revenue CNY 5.89bn (+4.9%); net income CNY -91.6M; gross margin 4.82%; liability ratio 56.6%Trough persists into Q1
8 May 20262025 AGMApproved accounts and the no-dividend plan
22 May 2026Board nominated the seventh board slateBoard renewal
~12 Jun 20262026 second EGM elected the seventh board; Li Qingwen re-elected ChairmanGovernance continuity
10 Jul 2026H1 2026 pre-announcement: net income CNY 110–121M (+375% to 424%); overseas trade up more than 50%Cyclical inflection
13 Jul 2026Institutional research visit (Kaiyuan Securities, Harvest Fund)Renewed buy-side interest
19–20 Aug 2026Convertible "Qixiang Zhuan 2" matured and was redeemed in cash; delistedRemoved the dilution overhang; reduced gross debt
25 Aug 2026H1 2026 report: revenue CNY 15.63bn (+28.0%); net income CNY 116.4M (+402.8%); OCF CNY 843MConfirmed recovery
14 Sep 2026Investor Q&A: MEK and MTBE prices off their March–April highs, but spreads still above Q4 2025; industry in a "weak recovery"Moderating tailwind
29–30 Sep 2026Chairman Li Qingwen resigned; Sun Qingtao became Chairman; Liu Fuliang became GM; Huang Liang became Deputy GM; Luan Fusheng nominated directorLeadership transition
8 Oct 2026Shares at about CNY 5.28, about 8% above the YE2025 close of CNY 4.88Market reaction modest

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

6 charts
Income Statement: Revenue & Gross Profit: Revenue fell from CNY 34,892 Mn in FY2021 to CNY 23,770 Mn in FY2025.
Zibo Qixiang Tengda Chemical Co., Ltd. — Income Statement: Revenue & Gross Profit
Series (CNY Mn)FY2021FY2022FY2023FY2024FY2025
Revenue34,89229,81026,91825,21923,770
Cost of revenue30,51527,24525,31723,83323,047
Gross profit4,3772,5651,6021,386723

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. Company FY2025 Annual Report summary, board resolutions, impairment, dividend, auditor, credit-line, FX-hedging, articles, AGM and "Quality and Return" notices (Shanghai Securities News, 10 Apr 2026) (paper.cnstock.com)
  2. FY2025 AR summary key figures (China Securities Journal, 10 Apr 2026) (epaper.cs.com.cn)
  3. FY2025 profit distribution notice (2026-009) and impairment notice (2026-007) · szse.io
  4. H1 2026 Semi-annual Report summary (2026-038, SZSE, 25 Aug 2026) (disc.static.szse.cn)
  5. H1 2026 Semi-annual Report full text (SZSE) (disc.static.szse.cn)
  6. H1 2026 profit pre-announcement (CLS, 10 Jul 2026) · Economic Herald via 10jqka
  7. Chairman / GM change announcement (2026-042, CNINFO, 30 Sep 2026) (static.cninfo.com.cn)
  8. Seventh board nomination (2026-022) and election results · paper.cnstock.com
  9. FY2024 AR summary (MEK capacity and share, butadiene context) · epaper.cs.com.cn
  10. FY2023 AR summary (paper.cnstock.com)
  11. FY2022 AR (auditor, dividend) (epaper.cs.com.cn)
  12. 2023 board documents (PDH/PO/acrylic status) (paper.cnstock.com)
  13. H1 2025 profit warning (2025-038) (epaper.cs.com.cn)
  14. Convertible conversion price decision (Dec 2025) (epaper.cs.com.cn)
  15. Standardized financials (S&P Global via StockAnalysis.com): income statement · balance sheet · cash flow · ratios
  16. Google Finance profile (employees, founding date) (google.com)
  17. Segment revenue (Lixinger) · executives
  18. FY2025 results commentary (Securities Star) · Q1 2026 and research visit
  19. Investor Q&A on spreads (Gelonghui, 14 Sep 2026) (m.gelonghui.com)
  20. Change of control history: TMTPost · Jiemian · CNStock · paper.cnstock.com · paper.cnstock.com
  21. CSRC penalties (Lanjinger) · Director uncontactable (NBD) · PAGAC (NBD)
  22. Project history: Yicai · China Securities Journal
  23. Che Chengju share-purchase plan (Q3 2023 report) (paper.cnstock.com)
  24. Qilu Keli catalyst project (FilingReader) (filingreader.com)
  25. Analyst ratings (Sohu) (q.stock.sohu.com)
  26. Secondary SWOT data (dcf-analysis, used only where flagged) (dcf-analysis.com)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.